Life sciences briefing: Tuesday, Feb. 26, 2008
TODAY’S HEADLINES:
Adnavance pulls in C$3.7M for molecular diagnostics, names new CEO (release)
“Personalized medicine” co. Proprius sells to Cypress Bio for up to $75M (release)
Vaccinex raises $25M in wake of GSK deal for antibody drugs (VentureWire)
Cianna Medical receives $9M for breast-cancer radiation treatment (release)
Electron-microscope image provider NanoImaging takes in $1.5M (release)
CrystalGenomics, ProQuest Investments create JV co. Palkion (release)
Portico Systems, software maker for insurance plans, raises $7.7M (release)
Stealthy biotech Affomic takes in $7M (peHUB)
Adnavance pulls in C$3.7M… Continue Reading
Life sciences briefing: Monday, Feb. 18, 2008
TODAY’S HEADLINES:
Sweden’s Elekta buys radiation-therapy software maker CMS for $75M (release)
Infusion-services firm Critical Homecare withdraws $125M IPO for buyout (Edgar)
NOTE: It’s a slow news day thanks to the President’s Day holiday. I’ll update with whatever else comes over the transom later today.
Sweden’s Elekta buys radiation-therapy software maker CMS for $75M – CMS, a St. Louis, Mo., developer of software for planning and managing radiation-therapy treatments, sold itself to Sweden’s Elekta for roughly $75 million in cash. The… Continue Reading
Life sciences briefing: Wednesday, Aug. 22, 2007
Featured companies: Alpex Pharma, Applied Computational Technologies, Separation Design Group, ThermalTherapeutics Systems
Switzerland’s Alpex Pharma raises $9M for plop, plop, fizz, fizz drugs– Alpex Pharma, a Mezzovico, Switzerland drug-formulation company, raised $9 million (CHF 10.9 million) in a second round of funding. Investors included BB Biotech Ventures and Signet Healthcare Partners.
The company essentially reformulates pharmaceuticals for other companies with technologies that make pills melt quickly, allowing them to be taken without water, or to “effervesce” — that… Continue Reading
Life sciences briefing: Friday, Aug. 17, 2007
Featured companies: Concentric Medical, Vertebration, Vision RT, Kemeta
Clotbuster Concentric Medical files for $69M IPO — Mountain View, Calif.-based Concentric Medical, which makes and markets devices for removing dangerous blood clots from the brains of stroke patients, filed to raise up to $69 million in an initial offering. The company’s devices consist of catheters that are threaded into the body’s circulatory system via the femoral artery in the groin and passed into the brain to the site… Continue Reading
ProCertus pulls in $2.3M for prevention of chemo, radiation side effects
ProCertus BioPharm, a Madison, Wis., company developing drugs to minimize the side effects of radiation and chemotherapy, raised $2.3 million in a first round of financing. The company will use the money to begin human tests of products such as DermX, which is supposed to prevent radiation-therapy induced dermatitis.
The round was led by Venture Investors, a significant Midwest-based healthcare and IT venture firm. Existing investors including the Novartis Venture Fund also joined the round.
These… Continue Reading
TomoTherapy, cancer-treatment system maker, gets enthusiastic IPO reception
TomoTherapy, a Madison, Wis.-based maker of imaging and radiation-treatment systems for cancer therapy, raised $222.3 million in an initial offering after its shares priced higher than the company’s original range.
TomoTherapy shares, which now trade under the symbol TTPY, priced at $19, well above the company’s expected range of $15 to $17, yielding net proceeds to the company of roughly $185 million. The stock opened this morning at $24. TomoTherapy makes and sells integrated devices that… Continue Reading